scholarly journals The shocking lack of evidence for implantable cardioverter defibrillators for heart failure; with or without cardiac resynchronization

2019 ◽  
Vol 40 (26) ◽  
pp. 2128-2130 ◽  
Author(s):  
John G F Cleland ◽  
Gerhard Hindricks ◽  
Mark Petrie
Keyword(s):  
Heart Failure ◽  
Cardiac Resynchronization ◽  
Implantable Cardioverter Defibrillators ◽  
Cardioverter Defibrillators

scholarly journals Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy in the Treatment of Heart Failure with Reduced Ejection Fraction

2017 ◽  
Vol 10 ◽  
Author(s):  
Ilaria Spoletini ◽  
Andrew Coats
Keyword(s):  
Heart Failure ◽  
Ejection Fraction ◽  
Cardiac Resynchronization Therapy ◽  
Cardiac Resynchronization ◽  
Implantable Cardioverter Defibrillators ◽  
Resynchronization Therapy ◽  
Device Therapy ◽  
Reduced Ejection Fraction ◽  
Patients With Heart Failure ◽  
Cardioverter Defibrillators

It has been long acknowledged that electrical-conduction disturbances may be both a cause of heart failure and a consequence of it. In fact, many patients with heart failure have an asynchronous contraction pattern of the heart muscle that further reduces the heart ability to pump blood. Electrical disturbances may therefore result in progressive left ventricular dysfunction, due to the added effects of HF-related electrical dyssynchrony. For this reason, device therapy may play a key role in the management of patients with heart failure and reduced ejection fraction (HFrEF). In particular, Implantable Cardioverter- Defibrillators (ICD) and Cardiac Resynchronization Therapy (CRT) may improve ejection fraction by reestablishing mechanical synchrony, possibly reversing symptoms and signs of heart failure, in addition to the more obvious role of ICD in terminating ventricular arrhythmias that threaten sudden death. Recommendations on device therapy from the current guidelines on heart failure management put out by the ESC/HFA in 2016 update our understanding of the evidence base for the use of ICD and CRT in HFrEF. We review these recommendations and the evidence behind them.

scholarly journals Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs

Sensors ◽  
2021 ◽  
Vol 21 (11) ◽  
pp. 3763
Author(s):  
Dominic A. M. J. Theuns ◽  
Sumant P. Radhoe ◽  
Jasper J. Brugts
Keyword(s):  
Heart Failure ◽  
Remote Monitoring ◽  
Point Of View ◽  
Cardiac Resynchronization ◽  
Current Status ◽  
Ambulatory Setting ◽  
Implantable Cardioverter Defibrillators ◽  
Frequent Monitoring ◽  
The Impact ◽  
Cardioverter Defibrillators

The management of heart failure remains challenging despite evidence-based medical and pharmacological advances, especially in the ambulatory setting. There is an urgent need to develop strategies to reduce hospitalizations and readmission rates due to heart failure. Frequent monitoring of high-risk patients is imperative, and with the development of wireless and remote technology, frequent monitoring is now possible via remote monitoring. Nowadays, remote management of patients with cardiac implantable electronic devices is being increasingly adopted and integrated into clinical practice. Several clinical trials studied the impact of remote monitoring on clinical outcomes in patients with implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization defibrillators (CRT-Ds). This point of view will focus on the remote monitoring of ICDs and CRT-Ds in patients with heart failure and discusses whether remote monitoring can be used as a potential instrument for the early identification of patients at risk of worsening heart failure.

Implantable Cardiac Devices in the Treatment of Arrhythmias and Congestive Heart Failure

2012 ◽  
Vol 9 (2) ◽  
pp. 99-104
Author(s):  
Soraya M Samii ◽  
Javier E Banchs
Keyword(s):  
Heart Failure ◽  
New Technology ◽  
Standard Of Care ◽  
Cardiac Resynchronization ◽  
Careful Examination ◽  
Implantable Cardioverter Defibrillators ◽  
Cardiac Devices ◽  
Implantable Cardiac Devices ◽  
Cardioverter Defibrillators ◽  
Improve Patient

The concept of using an implantable device to manage arrhythmias and heart failure started over 50 years ago. Since then, we have seen these devices improve patient outcomes from bradyarrhythmias, atrial fibrillation, ventricular arrhythmias, and heart failure. These devices are now standard of care in the management of patients and include pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) or combination devices. The future may hold expansion of the indications for these devices, with careful examination of the outcomes of today's patients. In addition, there is very exciting new technology that may further advance the management of arrhythmias and heart failure.

Implantable Cardiac Devices in the Treatment of Arrhythmias and Congestive Heart Failure

2012 ◽  
Vol 9 (1) ◽  
pp. 47-52
Author(s):  
Soraya M Samii ◽  
Javier E Banchs
Keyword(s):  
Heart Failure ◽  
New Technology ◽  
Standard Of Care ◽  
Cardiac Resynchronization ◽  
Careful Examination ◽  
Implantable Cardioverter Defibrillators ◽  
Cardiac Devices ◽  
Implantable Cardiac Devices ◽  
Cardioverter Defibrillators ◽  
Improve Patient

The concept of using an implantable device to manage arrhythmias and heart failure started over 50 years ago. Since then, we have seen these devices improve patient outcomes from bradyarrhythmias, atrial fibrillation, ventricular arrhythmias, and heart failure. These devices are now standard of care in the management of patients and include pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) or combination devices. The future may hold expansion of the indications for these devices, with careful examination of the outcomes of today's patients. In addition, there is very exciting new technology that may further advance the management of arrhythmias and heart failure.

Radionuclide Imaging in Heart Failure

2015 ◽  
Author(s):  
Prem Soman
Keyword(s):  
Heart Failure ◽  
Radionuclide Imaging ◽  
Imaging Techniques ◽  
Coronary Revascularization ◽  
Clinical Syndrome ◽  
Cardiac Resynchronization ◽  
Lv Function ◽  
Implantable Cardioverter Defibrillators ◽  
Failure State ◽  
Cardioverter Defibrillators

Heart Failure is a clinical syndrome characterized by symptoms and signs of systemic or pulmonary congestion, associated with elevated intracardiac filling pressures. The structural and functional abnormalities of the myocardium which characterize the heart failure state can be explored by various imaging approaches. Hence cardiac imaging plays an integral part in the evaluation the heart failure patient. Radionuclide imaging techniques may be uniquely suited to address several important clinical questions in heart failure related to etiology, the quantification and serial evaluation of LV function, and the selection of patients for therapies including coronary revascularization, implantable cardioverter-defibrillators (ICD) and cardiac resynchronization therapy (CRT).

Sign in / Sign up

Export Citation Format

Share Document